tiprankstipranks
Trending News
More News >
Doximity (DOCS)
NYSE:DOCS
US Market
Advertisement

Doximity (DOCS) Technical Analysis

Compare
869 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Doximity’s (DOCS) Moving Averages Convergence Divergence (MACD) indicator is 2.45, suggesting Doximity is a Sell.
Doximity’s (DOCS) 20-Day exponential moving average is 69.22, while Doximity’s (DOCS) share price is $73.6, making it a Buy.
Doximity’s (DOCS) 50-Day exponential moving average is 65.52, while Doximity’s (DOCS) share price is $73.6, making it a Buy.

Doximity (DOCS) Pivot Points

Sep 20, 2025, 05:42 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
70.10
70.70
71.69
72.29
73.28
73.88
74.87
Fibonacci
70.70
71.31
71.69
72.29
72.90
73.28
73.88
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Doximity (DOCS) Moving Averages

Sep 20, 2025, 05:42 AM
Period
Simple
Exponential
MA5
72.37Buy
72.33Buy
MA10
70.95Buy
71.14Buy
MA20
69.10Buy
69.22Buy
MA50
64.35Buy
65.52Buy
MA100
60.75Buy
62.48Buy
MA200
60.15Buy
59.19Buy
Doximity’s (DOCS) 10-Day exponential moving average is 71.14, while Doximity’s (DOCS) share price is $73.6, making it a Buy.
Doximity’s (DOCS) 100-Day exponential moving average is 62.48, while Doximity’s (DOCS) share price is $73.6, making it a Buy.
Doximity’s (DOCS) stock price is $73.6 and Doximity’s (DOCS) 50-day simple moving average is 64.35, creating a Buy signal.
Doximity’s (DOCS) stock price is $73.6 and Doximity’s (DOCS) 100-day simple moving average is 60.75, creating a Buy signal.
Doximity’s (DOCS) stock price is $73.6 and Doximity’s (DOCS) 200-day simple moving average is 60.15, creating a Buy signal.

Doximity (DOCS) Technical Indicators

Sep 20, 2025, 05:42 AM
Name
Value
Implied Action
RSI (14)
72.60
Sell
STOCH (9,6)
88.70
Sell
STOCHRSI (14)
92.02
Sell
MACD (12,26)
2.45
Sell
ADX (14)
36.68
Neutral
Williams %R
-5.27
Sell
CCI (14)
155.63
Sell
ATR (14)
1.85
-
Ultimate Oscillator
56.27
Neutral
ROC
7.62
Buy
Doximity’s (DOCS) Relative Strength Index (RSI) is 72.60, creating a Sell signal.
Doximity’s (DOCS) Trend Strength Indicator (ADX) is 36.68, creating a Neutral signal.
Doximity’s (DOCS) Commodity Channel Index (CCI) is 155.63, creating a Sell signal.
Doximity’s (DOCS) Price Rate of Change (ROC) is 7.62, creating a Buy signal.

FAQ

Is DOCS a Buy, Hold, or Sell?
Based on DOCS’s technical indicators, DOCS is a Buy.
    What is DOCS’s RSI (14)?
    DOCS’s RSI (14) is 72.60, which suggests DOCS is a Sell.
      What is DOCS’s MACD?
      DOCS’s MACD is 2.45, which suggests DOCS is a Sell.
        What is DOCS’s 5-day moving average?
        DOCS’s 5-day moving average is 72.37, which suggests DOCS is a Buy.
          What is DOCS’s 20-day moving average?
          DOCS 20-day moving average is 69.10, which suggests DOCS is a Buy.
            What is DOCS’s 50-day moving average?
            DOCS’s 50-day moving average is 64.35, which suggests DOCS is a Buy.
              What is DOCS’s 200-day moving average?
              DOCS’s 200-day moving average is 60.15, which suggests DOCS is a Buy.
                What is DOCS’s Williams % R (14)?
                DOCS’s Williams % R (14) is -5.27, which suggests DOCS is a Sell.
                  What is DOCS’s CCI (14)?
                  DOCS’s CCI (14) is 155.63, which suggests DOCS is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis